2014 Archived Articles
Characterization of Drug-Product-Related Impurities and Variants of a Therapeutic Monoclonal Antibody by Higher Energy C‑Trap Dissociation Mass Spectrometry
Analytical Chemistry, December, 2014
Contributing Authors
Deyun Wang, Principal Scientist, Eurofins Lancaster Laboratories
Colin Wynne, Senior Scientist, Eurofins Lancaster Laboratories
Strategically Engaging Clients to Meet their Unique Outsourcing and Insourcing Needs
Pharmaceutical Technology Europe, November, 2014
Author
Michael McDowell, Vice President, Business Development and Project Management, Eurofins Lancaster Laboratories
Outsourcing & Insourcing: Considerations for Biopharmaceutical Testing
An American Pharmaceutical Review Supplement published in October, 2014
Authors
Charles Ducker, Ph.D., Principal Chemist
Jon S. Kauffman, Ph.D., Senior Director, Biochemistry and Method Development/Validation
Weihong Wang, Ph.D., Technology Development Manager
Kate Bergmann, Ph.D., Manager, Viral Safety and Viral Clearance Services
Jeri Ann Boose, Ph.D., Senior Director, Biopharmaceutical Services
Beth DiPaolo, MA, SPHR, President, Professional Scientific Services
Cell Based Potency Assays: From Science to Quality Control
European Biopharmaceutical Review, July, 2014
Author
Weihong Wang, PhD, Technology Development Manager, Eurofins Lancaster Laboratories
Cell Banking Interview with Dr. Jeri Ann Boose
American Pharmaceutical Review, June, 2014
Author
Jeri Ann Boose, PhD, Senior Director, Eurofins Lancaster Laboratories
Product Hub: Eurofins BioPharma Product Testing
European Pharmaceutical Review, April, 2014
Author
Timothy S. Oostdyk, PhD, President of Eurofins Lancaster Laboratories; Sr. Vice President, Eurofins BioPharma Product Testing
Analytical Testing of Biologics & Biosimilars
Drug Development & Delivery, March, 2014
Contributing Author
Michael McDowell, Vice President, Business Development & Project Management
Biologics Production and Single-Use Technologies: Challenges, Trends and Techniques
American Pharmaceutical Review, February, 2014
Contributing Author
Dr. Jeri Ann Boose, Senior Director Biopharmaceutical Services